» Authors » Hiro Sato

Hiro Sato

Explore the profile of Hiro Sato including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 82
Citations 1472
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Miyasaka Y, Kawamura H, Sato H, Kubo N, Katoh H, Ishikawa H, et al.
Adv Radiat Oncol . 2024 May; 9(4):101432. PMID: 38778824
Purpose: Treatment outcomes of definitive photon radiation therapy for nonmetastatic castration-resistant prostate cancer (nmCRPC) are reportedly unsatisfactory. Carbon ion radiation therapy (CIRT) has shown favorable tumor control in various malignancies,...
2.
Haruna S, Okuda K, Shibata A, Isono M, Tateno K, Sato H, et al.
Radiother Oncol . 2024 Mar; 194:110198. PMID: 38438016
Background And Purpose: Ionizing radiation (IR) induces DNA double-strand breaks (DSBs), leading to micronuclei formation, which has emerged as a key mediator of inflammatory responses after IR. This study aimed...
3.
Yoshimura N, Kariya R, Shimada M, Tateyama M, Matsunaga H, Shibata Y, et al.
Sci Rep . 2023 Dec; 13(1):21572. PMID: 38062130
Osteosarcoma is rare but is the most common bone tumor. Diagnostic tools such as magnetic resonance imaging development of chemotherapeutic agents have increased the survival rate in osteosarcoma patients, although...
4.
Okami H, Ozawa N, Sohda M, Yokobori T, Osone K, Erkhem-Ochir B, et al.
Int J Mol Sci . 2023 Sep; 24(17). PMID: 37686454
Human leukocyte antigen class I (HLA-I) is considered a genetic pathogen for ulcerative colitis (UC). This study aimed to investigate the significance of DNA damage and HLA-I expression in infiltrating...
5.
Musha A, Kubo N, Kawamura H, Okano N, Sato H, Okada K, et al.
Cancer Rep (Hoboken) . 2023 Apr; 6(7):e1825. PMID: 37115713
Background: Carbon-ion radiotherapy (C-ion RT) is effective for head and neck mucosal melanoma (HN-MM), including radioresistant mucosal melanoma. Melanoma also responds effectively to immune checkpoint inhibitors (ICIs). Data on the...
6.
Miyasaka Y, Yoshimoto Y, Ando K, Murata K, Irie D, Sato H, et al.
Anticancer Res . 2023 Apr; 43(5):2077-2084. PMID: 37097697
Background/aim: Prognostic factors, including CD8-positive tumor-infiltrating lymphocytes (CD8TILs), in definitive radiotherapy (RT) for squamous cell carcinoma (SqCC) of the uterine cervix need to be studied. This study aimed to explore...
7.
Mizukami T, Kawamura H, Kubo N, Sato H, Kawahara M, Adachi A, et al.
Asia Pac J Clin Oncol . 2023 Apr; 20(3):365-371. PMID: 37088970
Aim: This study aimed to report initial results of hypofractionated carbon-ion radiotherapy (C-ion RT) for inoperable upper tract ureteral cancer. Methods: Retrospective chart review was performed for five consecutive patients...
8.
Ruan H, Oike T, Sato H, Ando K, Ohno T
Cancers (Basel) . 2023 Feb; 15(4). PMID: 36831552
Background: Tumor mutational burden (TMB) and stromal CD8-positive tumor-infiltrating lymphocytes (CD8TILs) serve important roles in antitumor immune responses to radiotherapy. This study aimed to elucidate the association between TMB, CD8TILs,...
9.
Okada K, Sato H, Kumazawa T, Mori Y, Permata T, Uchihara Y, et al.
Adv Radiat Oncol . 2023 Feb; 8(3):101159. PMID: 36793509
Purpose: Understanding the immune response during radiation therapy (RT) in a clinical setting is imperative for maximizing the efficacy of combined RT and immunotherapy. Calreticulin, a major damage-associated molecular pattern...
10.
Imamura A, Oike T, Sato H, Yoshimoto Y, Ando K, Ohno T
Anticancer Res . 2022 Jul; 42(7):3341-3348. PMID: 35790266
Background/aim: This study aimed to elucidate the effect of radiotherapy on expression of immune response-related genes in cervical cancer tissues. Materials And Methods: Tumor tissues were obtained from 16 patients...